164 related articles for article (PubMed ID: 3435701)
1. Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.
Sehested M; Skovsgaard T; van Deurs B; Winther-Nielsen H
Br J Cancer; 1987 Dec; 56(6):747-51. PubMed ID: 3435701
[TBL] [Abstract][Full Text] [Related]
2. Freeze-fracture study of plasma membranes in wild type and daunorubicin-resistant Ehrlich ascites tumor and P388 leukemia cells.
Sehested M; Simpson D; Skovsgaard T; Buhl-Jensen P
Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(5):327-35. PubMed ID: 2565630
[TBL] [Abstract][Full Text] [Related]
3. Verapamil reverses the ultrastructural alterations in the plasma membrane induced by drug resistance.
García-Segura LM; Soto F; Planells-Cases R; Gonzalez-Ros JM; Ferragut JA
FEBS Lett; 1992 Dec; 314(3):404-8. PubMed ID: 1468576
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural alterations in plasma membranes from drug-resistant P388 murine leukemia cells.
García-Segura LM; Ferragut JA; Ferrer-Montiel AV; Escriba PV; Gonzalez-Ros JM
Biochim Biophys Acta; 1990 Nov; 1029(1):191-5. PubMed ID: 1977472
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics of anthracycline-resistant strains of P388 leukemia].
Goncharova SA; Demidova NS; Shiriaeva OA; Shevtsova VN; Konovalova NP
Eksp Onkol; 1987; 9(4):42-7. PubMed ID: 3678124
[TBL] [Abstract][Full Text] [Related]
6. Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines.
Sehested M; Skovsgaard T; van Deurs B; Winther-Nielsen H
J Natl Cancer Inst; 1987 Jan; 78(1):171-9. PubMed ID: 3467125
[TBL] [Abstract][Full Text] [Related]
7. Comparison of daunorubicin and anthrapyrazolone sensitivity and transport in resistant cell lines.
McGown A; Poppitt DG; Fox BW
Br J Cancer; 1987 Dec; 56(6):752-4. PubMed ID: 3435702
[TBL] [Abstract][Full Text] [Related]
8. The carboxylic ionophore monensin inhibits active drug efflux and modulates in vitro resistance in daunorubicin resistant Ehrlich ascites tumor cells.
Sehested M; Skovsgaard T; Roed H
Biochem Pharmacol; 1988 Sep; 37(17):3305-10. PubMed ID: 3401258
[TBL] [Abstract][Full Text] [Related]
9. Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance.
Slater LM; Murray SL; Wetzel MW; Sweet P; Stupecky M
Cancer Chemother Pharmacol; 1986; 16(1):50-4. PubMed ID: 3455667
[TBL] [Abstract][Full Text] [Related]
10. Influx of daunorubicin in multidrug resistant Ehrlich ascites tumour cells: correlation to expression of P-glycoprotein and efflux. Influence of verapamil.
Nielsen D; Maare C; Skovsgaard T
Biochem Pharmacol; 1995 Aug; 50(4):443-50. PubMed ID: 7646548
[TBL] [Abstract][Full Text] [Related]
11. [Role of intracellular pH in the development of resistance of leukemic cells to antineoplastic drugs].
Shestova OL; Ogloblina TA; Litinskaia LL
Eksp Onkol; 1990; 12(3):61-2. PubMed ID: 2344828
[TBL] [Abstract][Full Text] [Related]
12. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
Kessel D; Wilberding C
Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
[TBL] [Abstract][Full Text] [Related]
13. Effects of verapamil on daunomycin cellular retention and cytotoxicity in P388 leukemic cells.
Yanovich S; Preston L
Cancer Res; 1984 May; 44(5):1743-7. PubMed ID: 6713377
[TBL] [Abstract][Full Text] [Related]
14. Lectin staining patterns of plasma membranes of daunorubicin and vincristine resistant Ehrlich ascites tumour cells.
Sehested M; Skovsgaard T
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 54(6):366-70. PubMed ID: 2453973
[TBL] [Abstract][Full Text] [Related]
15. Correction of altered plasma membrane potentials. A possible mechanism of cyclosporin A and verapamil reversal of pleiotropic drug resistance in neoplasia.
Vayuvegula B; Slater L; Meador J; Gupta S
Cancer Chemother Pharmacol; 1988; 22(2):163-8. PubMed ID: 3165724
[TBL] [Abstract][Full Text] [Related]
16. [Sensitivity to chemotherapeutic preparations of anthracycline-resistant strains of murine leukemia P388].
Demidova NS; Goncharova SA; Shiriaeva OA; Konovalova NP
Eksp Onkol; 1989; 11(1):65-8. PubMed ID: 2924713
[TBL] [Abstract][Full Text] [Related]
17. Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites carcinoma.
Slater LM; Murray SL; Wetzel MW; Wisdom RM; DuVall EM
J Clin Invest; 1982 Nov; 70(5):1131-4. PubMed ID: 6182160
[TBL] [Abstract][Full Text] [Related]
18. Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy.
Yanovich S; Taub RN
Cancer Res; 1983 Sep; 43(9):4167-71. PubMed ID: 6871858
[TBL] [Abstract][Full Text] [Related]
19. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
[TBL] [Abstract][Full Text] [Related]
20. Non-antitumor vinca alkaloids reverse multidrug resistance in P388 leukemia cells in vitro.
Inaba M; Nagashima K
Jpn J Cancer Res; 1986 Feb; 77(2):197-204. PubMed ID: 3082832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
